NO162094C - Fremgangsmaate for bestemmelse av lavdensitetslipoprotein (ldl) og reagens for gjennomfoering av den. - Google Patents

Fremgangsmaate for bestemmelse av lavdensitetslipoprotein (ldl) og reagens for gjennomfoering av den.

Info

Publication number
NO162094C
NO162094C NO831428A NO831428A NO162094C NO 162094 C NO162094 C NO 162094C NO 831428 A NO831428 A NO 831428A NO 831428 A NO831428 A NO 831428A NO 162094 C NO162094 C NO 162094C
Authority
NO
Norway
Prior art keywords
ldl
low density
reagents
implementing
procedure
Prior art date
Application number
NO831428A
Other languages
English (en)
Norwegian (no)
Other versions
NO831428L (no
NO162094B (no
Inventor
Joachim Ziegenhorn
Sigbert Schiefer
Birgitte Draeger
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO831428L publication Critical patent/NO831428L/no
Publication of NO162094B publication Critical patent/NO162094B/no
Publication of NO162094C publication Critical patent/NO162094C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • Semiconductor Lasers (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
NO831428A 1982-04-23 1983-04-22 Fremgangsmaate for bestemmelse av lavdensitetslipoprotein (ldl) og reagens for gjennomfoering av den. NO162094C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823215310 DE3215310A1 (de) 1982-04-23 1982-04-23 Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung

Publications (3)

Publication Number Publication Date
NO831428L NO831428L (no) 1983-10-24
NO162094B NO162094B (no) 1989-07-24
NO162094C true NO162094C (no) 1989-11-01

Family

ID=6161825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831428A NO162094C (no) 1982-04-23 1983-04-22 Fremgangsmaate for bestemmelse av lavdensitetslipoprotein (ldl) og reagens for gjennomfoering av den.

Country Status (15)

Country Link
US (2) US5407836A (enExample)
EP (1) EP0092801B1 (enExample)
JP (1) JPS58191967A (enExample)
AT (1) ATE17404T1 (enExample)
AU (1) AU539195B2 (enExample)
CA (1) CA1211707A (enExample)
DE (2) DE3215310A1 (enExample)
DK (1) DK159840C (enExample)
ES (1) ES521757A0 (enExample)
FI (1) FI77538C (enExample)
HU (1) HU190836B (enExample)
IE (1) IE54314B1 (enExample)
NO (1) NO162094C (enExample)
SU (1) SU1296019A3 (enExample)
ZA (1) ZA832842B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319066A1 (de) * 1983-05-26 1984-11-29 Claus-Christian Dr.Rer.Nat. Dr.Med. 6901 Wilhelmsfeld Heuck Verfahren und reagenz zum direkten nachweis eines analyts nach spezifischer entfernung von colloidpartikeln in waessrigen loesungen biologischer herkunft
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
JPH02242158A (ja) * 1989-03-15 1990-09-26 Nippon Shoji Kk ヒトアポリポ蛋白ｃ―３の測定法
USRE39915E1 (en) 1989-09-01 2007-11-06 Roche Diagnostics Gmbh Method for the determination of HDL cholesterol by means of a rapid diagnostic agent with an integrated fractionating step
DE3929032C2 (de) * 1989-09-01 1998-09-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von HDL-Cholesterin mittels eines Schnelldiagnostikums mit integriertem Fraktionierschritt
US5213965A (en) * 1990-07-16 1993-05-25 Cholestech Corporation Solid-phase precipitation assay device
US5213964A (en) * 1990-07-16 1993-05-25 Cholestech Corporation High-density lipoprotein solid-base precipitation assay method
US5034332A (en) * 1990-08-06 1991-07-23 Wisconsin Alumni Research Foundation Assay for high density lipoprotein cholesterol
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas
DE69615956T2 (de) 1995-07-21 2002-06-20 Wako Pure Chem Ind Ltd Methode zur Messung der Menge eines in einem spezifischen Lipoprotein enthaltenen Bestandteils
RU2151403C1 (ru) * 1997-08-26 2000-06-20 Рагино Юлия Игоревна Способ определения резистентности к окислению липопротеинов низкой плотности сыворотки крови
RU2164690C2 (ru) * 1998-11-16 2001-03-27 Кировский государственный медицинский институт Способ диагностики патологического течения климактерического периода
JP3441993B2 (ja) 1999-01-27 2003-09-02 松下電器産業株式会社 コレステロールセンサ
WO2001038862A1 (en) 1999-11-22 2001-05-31 Matsushita Electric Industrial Co., Ltd. Cholesterol sensor and method for determining cholesterol
EE200200238A (et) * 2000-09-04 2003-06-16 Kim Hyo-Joon Apolipoproteiin B-100 epitoobi mimeetpeptiidid, nende konkatemeer ja modifitseeritud peptiidid ningneid sisaldavad vaktsiinikompositsioonid
US6898728B2 (en) * 2001-09-25 2005-05-24 Sun Microsystems, Inc. System domain targeted, configurable interconnection
WO2003056163A1 (en) * 2001-12-21 2003-07-10 Polymer Technology Systems, Inc. Test strip and method for determining hdl cholesterol concentration from whole blood of plasma
EP1357383B1 (en) 2002-04-09 2005-11-09 Cholestech Corporation High-density lipoprotein assay device and method
US7772007B2 (en) * 2004-04-02 2010-08-10 Cholestech Corporation Assay device for direct measurement of LDL cholesterol
US7491542B2 (en) * 2004-07-12 2009-02-17 Kim Scheuringer Test device for determining the concentration of LDL-cholesterol in a sample
WO2010002478A2 (en) * 2008-07-03 2010-01-07 University Of Georgia Research Foundation, Inc. Glycopeptide and uses thereof
WO2008086019A1 (en) 2007-01-09 2008-07-17 Cholestech Corporation Device and method for measuring ldl-associated cholesterol
KR102211991B1 (ko) * 2011-11-11 2021-02-05 엑시스-시일드 에이에스 혈액 샘플 분석 방법
RU2501013C1 (ru) * 2012-07-26 2013-12-10 Батожаб Батожаргалович Шойбонов Способ определения минимально модифицированных липопротеинов низкой плотности в сыворотке или плазме крови человека
RU2497116C1 (ru) * 2012-08-10 2013-10-27 Батожаб Батожаргалович Шойбонов Способ определения атерогенности крови человека

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039285A (en) * 1975-10-10 1977-08-02 Ortho Diagnostics, Inc. Single sample method for determination of lipoprotein concentrations in blood
DE2600664C3 (de) * 1976-01-09 1980-10-23 Claus-Christian Dr.Rer.Nat. Dr.Med. 6901 Wilhelmsfeld Heuck Verfahren zur direkten Bestimmung des ß -Cholesteringehaltes im Blutserum
US4184921A (en) * 1976-03-25 1980-01-22 Boehringer Mannheim Gmbh Process and reagent for determining cholesterol
DE2612725C3 (de) * 1976-03-25 1979-05-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagenz zur Bestimmung von Cholesterin
NL7701800A (nl) * 1977-02-18 1978-08-22 Akzo Nv Testkit en methode voor de bepaling van lp-x.
US4190628A (en) * 1977-11-21 1980-02-26 Trustees Of Boston University Kit for determining the level of LDL cholesterol in body fluids
FR2455743A1 (fr) * 1979-05-02 1980-11-28 Goella Laboratoires Procede et dispositif pour le dosage des lipoproteines seriques
DE3009037A1 (de) * 1980-03-08 1981-09-24 Boehringer Mannheim Gmbh Verfahren zur direkten bestimmung des lipidgehaltes der (beta) -lipoproteine des blutes
DE3117455A1 (de) * 1981-05-02 1982-11-25 Boehringer Mannheim Gmbh Reagens zur praezipitation apo-b-haltiger lipoproteine, verfahren zu dessen herstellung und dessen verwendung bei der bestimmung von hdl-cholesterin
DE3208253A1 (de) * 1982-03-08 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur spezifischen bestimmung des cholesterins der ldl-fraktion im serum

Also Published As

Publication number Publication date
IE830823L (en) 1983-10-23
FI831359A0 (fi) 1983-04-21
DK175383A (da) 1983-10-24
HU190836B (en) 1986-11-28
JPH0375825B2 (enExample) 1991-12-03
ATE17404T1 (de) 1986-01-15
AU539195B2 (en) 1984-09-13
NO831428L (no) 1983-10-24
AU1343783A (en) 1983-10-27
NO162094B (no) 1989-07-24
DE3215310A1 (de) 1983-10-27
US5407836A (en) 1995-04-18
CA1211707A (en) 1986-09-23
FI77538C (fi) 1989-03-10
ZA832842B (en) 1984-01-25
JPS58191967A (ja) 1983-11-09
DK159840C (da) 1991-04-29
EP0092801B1 (de) 1986-01-08
EP0092801A1 (de) 1983-11-02
SU1296019A3 (ru) 1987-03-07
ES8402426A1 (es) 1984-02-01
FI77538B (fi) 1988-11-30
IE54314B1 (en) 1989-08-16
DE3361763D1 (en) 1986-02-20
FI831359L (fi) 1983-10-24
DK159840B (da) 1990-12-10
DK175383D0 (da) 1983-04-21
US5532172A (en) 1996-07-02
ES521757A0 (es) 1984-02-01

Similar Documents

Publication Publication Date Title
NO162094C (no) Fremgangsmaate for bestemmelse av lavdensitetslipoprotein (ldl) og reagens for gjennomfoering av den.
DE3471758D1 (en) Process for the determination of low-density lipoproteins and reagent therefor
DE3382716D1 (de) Verfahren zur Wärmebehandlung von Plasma oder Plasmafraktionen und so erhaltene Zusammensetzungen.
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
ES525361A0 (es) Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.
DE3381062D1 (de) Verfahren und anordnung zur minimum/maximum-bestimmung von datenwoertern.
SG52497A1 (en) Separation procedure for LP(A) by means of electrophoresis gels for the implementation of this procedure & application to the in vitro (pls see file for full title)
DK407987A (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
DK406184D0 (da) Fremgangsmaade til pasteurisering af humanplasma
FI822224A0 (fi) Stabiliseringsfoerfarande
DE3485376D1 (de) Elektroneneinschlag-ionenquelle zur analysierung von komponenten.
DE3580631D1 (de) Methode zur trennung von blutbestandteilen.
DE3485711D1 (de) Immunoadsorbens und verfahren zur zurueckgewinnung von vitamin-k-abhaengigen proteinen mittels dieses adsorbens.
DK528279A (da) Fremgangsmaade til isolering af hepatitis b e antigen eller antistof
DK512584A (da) Fremgangsmaade til forarbejdning af dyreblod og fraktioner deraf
DE69111637D1 (de) Verfahren zur Trennung und Konzentration von Phosphopeptiden.
DK162604C (da) Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel
SE8403841L (sv) Blodtappningsvagga
BR8205912A (pt) Processo de separacao das proteinas contidas nas turfas hidricas, (sapropelitos).

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001